{"entity":{"id":"nct03052127","kind":"trial","name":"Study in Subjects With Small Primary Choroidal Melanoma","aka":[],"tldr":"A phase 1/2 trial of Belzupacap sarotalocan run by Aura Biosciences, completed.","summary":"Study in Subjects With Small Primary Choroidal Melanoma is a phase 1/2 interventional study registered as NCT03052127 by Aura Biosciences, with 57 participants enrolled, started 2017-02-27. Conditions recorded: Uveal Melanoma, Ocular Melanoma and Choroidal Melanoma. Interventions recorded: Light-activated AU-011 and Laser Activation.","status":"completed","asOf":"2026-11-03","links":[{"label":"ClinicalTrials.gov NCT03052127","url":"https://clinicaltrials.gov/study/NCT03052127"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["uveal-melanoma"],"sections":[],"technologies":[],"targets":[],"drugs":["belzupacap-sarotalocan"],"companies":["aura-biosciences"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT03052127","phase":"1/2","setting":"A Phase 1B/2 Open-Label, Ascending Single and Repeat Dose Clinical Trial Designed to Evaluate the Safety and Efficacy of Light-activated AU-011 for the Treatment of Subjects With Small Primary Choroidal Melanoma","sponsor":"Aura Biosciences","enrolled":57,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct03052127/","neighbours":{"cancer":[{"id":"uveal-melanoma","kind":"cancer","name":"Uveal melanoma","route":"/cancers/uveal-melanoma/"}],"drug":[{"id":"belzupacap-sarotalocan","kind":"drug","name":"Belzupacap sarotalocan","route":"/drugs/belzupacap-sarotalocan/"}],"company":[{"id":"aura-biosciences","kind":"company","name":"Aura Biosciences","route":"/companies/aura-biosciences/"}]}}